UPDATE: Barclays Downgrades Prelude Therapeutics (PRLD) to Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: PRLD) | Delayed: 3.78 -0.06 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.84 | 52 Week High | $ | |||
| Open | $3.87 | 52 Week Low | $ | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $3.76 | EPS | $ | |||
| Volume | 174,752 | |||||
